Breast Cancer (Clinical Trial)

New Study Designed To Improve Outcomes in Women With Metastatic Disease

Published in Women's Health Weekly, June 22nd, 1998

Researchers at the University of Kentucky (UK) Markey Cancer Center recently announced the beginning of a novel clinical trial designed to improve the outcome of metastatic breast cancer in some women.

Decades of research with traditional anti-cancer therapies, such as conventional chemotherapy and hormone manipulation, have improved outcomes only marginally, although many women do live longer as a result.

"Women with advanced breast cancer benefit from transplants, but are rarely cured," said Kenneth Foon, MD, chief of hematology/oncology and director of the UK Markey Cancer Center, Lexington, Kentucky. "It is our hope that by adding a vaccine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1998-06-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry